Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2012 by Clalit Health Services.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Timna Naftali, Clalit Health Services Identifier:
First received: December 15, 2011
Last updated: October 28, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)